Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers

Israeli Stocks: Bank Leumi, Teva, Africa-Israel, Suny Electronic

Israel’s TA-25 Index gained for a second day, climbing 0.8 percent to 1,107.55 at the 4:30 p.m. close in Tel Aviv. The measure dropped 18 percent last year. Investors traded about 932 million shekels ($244 million) of shares and convertible securities, according to bourse data.

The following stocks rose or fell today. Symbols are in parenthesis.

Africa-Israel Investments Ltd. (AFIL IT) climbed for a second day, advancing 9 percent to 13.11 shekels, bringing the two day surge to 14 percent. The holding company of billionaire Lev Leviev said yesterday it would buy back bonds for as much as 1 billion shekels during 2012.

Bank Leumi Le-Israel Ltd. (LUMI IT) increased 1.4 percent to 11.30 shekels, the highest level since Dec. 27. Israel’s largest lender by assets said Chief Executive Officer Galia Maor will step down in the second quarter after 16 years as one of the nation’s most prominent female business leaders.

Suny Electronic Ltd. (SUNY IT) soared to the highest in almost a month, rising 15 percent to 10.59 shekels. The shares have surged 35 percent in two days, bringing the company’s market value to 326 million shekels. The importer of mobile phones said shareholder Ilan Ben Dov acquired shares and bonds.

Teva Pharmaceutical Industries Ltd. (TEVA IT) gained 3.3 percent, the biggest jump since Nov. 3, to 160.60 shekels. The world’s largest maker of generic drugs said Jeremy Levin, a former executive at Bristol-Myers Squibb, will replace Chief Executive Officer Shlomo Yanai.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.